
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Samples from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/samples/topic/12038/</link>
        <description>Articles tagged with Samples from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Business briefs: Lundbeck, FDA, Tower Watson and National Business Group Study, Merck</title>
          <description>Lundbeck and Otsuka deepen their Abilify co-promotion partnership; study finds FDA clinical trial rule isn&apos;t sticking; another study confirms that employees are paying more for health insurance as employers pay less; Merck appoints new R&amp;D chief</description>
          <link>http://www.mmm-online.com/business-briefs-lundbeck-fda-tower-watson-and-national-business-group-study-merck/article/283382/</link>
          <pubDate>Thu, 07 Mar 2013 17:01:19 GMT</pubDate>
          <itunes:summary>Lundbeck and Otsuka deepen their Abilify co-promotion partnership; study finds FDA clinical trial rule isn&apos;t sticking; another study confirms that employees are paying more for health insurance as employers pay less; Merck appoints new R&amp;D chief</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Sales forces shrank in 2011, but not everywhere</title>
          <description>Pharmas shrank their US sales forces by 7% between 2010 and 2011, but the pain wasn&apos;t shared evenly between the biggest of pharmas, as a number of players scaled up.</description>
          <link>http://www.mmm-online.com/sales-forces-shrank-in-2011-but-not-everywhere/article/241446/</link>
          <pubDate>Wed, 16 May 2012 18:07:17 GMT</pubDate>
          <itunes:summary>Pharmas shrank their US sales forces by 7% between 2010 and 2011, but the pain wasn&apos;t shared evenly between the biggest of pharmas, as a number of players scaled up.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Pfizer, Crestor tops for global promotional spend in 2011</title>
          <description>Total global pharma promotional spending fell 3.4% to $92.2 billion in 2011, according to Cegedim Strategic Data, led by a 4.7% decline in detailing spend.</description>
          <link>http://www.mmm-online.com/pfizer-crestor-tops-for-global-promotional-spend-in-2011/article/238922/</link>
          <pubDate>Tue, 01 May 2012 12:00:00 GMT</pubDate>
          <itunes:summary>Total global pharma promotional spending fell 3.4% to $92.2 billion in 2011, according to Cegedim Strategic Data, led by a 4.7% decline in detailing spend.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Samples no longer hold sway in pharma marketing mix: study</title>
          <description>Over the last four years, drugmakers have slashed support for samples as they rethink what once was an essential part of their marketing mix.</description>
          <link>http://www.mmm-online.com/samples-no-longer-hold-sway-in-pharma-marketing-mix-study/article/228680/</link>
          <pubDate>Tue, 21 Feb 2012 21:14:31 GMT</pubDate>
          <itunes:summary>Over the last four years, drugmakers have slashed support for samples as they rethink what once was an essential part of their marketing mix.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>One fourth of family medicine residencies &quot;pharma free,&quot; says survey</title>
          <description>Most US family medicine resident programs have limits on drug industry interaction with doctors, and a quarter shun doctor-company contacts altogether, said a survey by Georgetown University Medical Center and the American Medical Student Association.</description>
          <link>http://www.mmm-online.com/one-fourth-of-family-medicine-residencies-pharma-free-says-survey/article/199268/</link>
          <pubDate>Fri, 25 Mar 2011 20:39:04 GMT</pubDate>
          <itunes:summary>Most US family medicine resident programs have limits on drug industry interaction with doctors, and a quarter shun doctor-company contacts altogether, said a survey by Georgetown University Medical Center and the American Medical Student Association.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  